Greenwald analyzes the government’s updated national HIV/AIDS strategy

Robert Greenwald, director of the Center for Health Law and Policy Innovation and a clinical professor of law at Harvard Law School, has co-authored an editorial with David Holtgrave, Ph.D., professor and chair of the Department of Health, Behavior and Society at Johns Hopkins Bloomberg School of Public Health, on the updated National HIV/AIDS Strategy (NHAS) from the federal government.

CHLPI study finds life-threatening barriers in access to breakthrough Hepatitis C drugs

A team of researchers from Harvard Law School’s Center for Health Law and Policy Innovation, Brown University’s Department of Medicine, Rhode Island’s Miriam Hospital, Treatment Action Group, and Kirby Institute of Australia, has released findings from a nationwide study of Medicaid policies for the treatment of hepatitis C virus (HCV), which affects over 3 million Americans.

CHLPI launches campaign to promote federal law and policy reforms for type 2 diabetes

On May 19, the Harvard Law School Center for Health Law and Policy Innovation (CHLPI) launched a campaign to promote federal law and policy reforms for type 2 diabetes prevention and management as part of CHLPI’s broader, multi-phase Providing Access to Healthy Solutions (PATHS) initiative that first worked to strengthen local and state policy to address diet-related health conditions.